MedTrace Logo

Hepatic Function and Bile Acid in Preterm Infants Receiving Parenteral Lipids Emulsion

NCT01786759 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-02-08

No results posted yet for this study

Summary

The etiology of parenteral nutrition-associated cholestasis(PNAC)although elusive is thought to be multifactorial, and proposed theories also include problems arising from lipid emulsions, leading us to explore alternative products available elsewhere.So we compare the different fat emulsion, and want to see if the olive oil lipid emulsions can improve hepatic tolerance in preterm infant.

Conditions

  • Preterm Infants

Interventions

DRUG

ClinOleic

the lipid of all-in-one, 0.5-3.5g/kg.d

DRUG

Intralipid

the lipid of all-in-one, 0.5-3.5g/kg.d

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Wei Cai, PhD · Xin Hua Hospital

  • Ying Wang, PhD · Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-05-31
Completion
2013-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01786759 on ClinicalTrials.gov